Pharmaceuticals Global On demand · 24-48h

Global Horses Joint Care Products Market Strategic Research Report

Global Horses Joint Care Products Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Horses Joint Care Products Market
$1202025
4.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Joint Therapeutic Products, Joint Supplement Products

By Application: Horse Racing, Equestrian Club, Animal Healthcare, Animal Husbandry, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Boehringer Ingelheim, Bayer Animal, Dechra, Ceva, Vetoquinol, Cosequin, Hilton Herbs, Audevard, Virbac, Noltrex, Med - Vet Pharmaceuticals, SmartPak, Nutramax Laboratories, Equine America, Animalife, Platinum Performance, Cox Vet Labs, 4Cyte, ADM Protexin, Arthramid, Adequan

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 164 pages
Market size 2025
$120
Million USD
Forecast CAGR
4.4%
2025-2032
Forecast 2032
$162.2
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Horses Joint Care Products market size is predicted to grow from US$ 120 million in 2025 to US$ 161 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.

In 2024, the global cost of equine joint care products will be approximately RMB 298.78/meter, with a gross profit margin of 22.73%.

Horses Joint Care Products refer to a range of specialized supplements, medications, and topical treatments designed to support and maintain the health of a horse's joints. These products aim to alleviate pain, reduce inflammation, and enhance mobility in horses, particularly those involved in strenuous activities like racing, jumping, or heavy work. They typically contain ingredients such as glucosamine, chondroitin sulfate, hyaluronic acid, and omega-3 fatty acids, which help to lubricate joints, repair cartilage, and reduce discomfort. Proper joint care is crucial for ensuring a horse's long-term performance, comfort, and overall well-being, making these products an essential part of equine healthcare.

The upstream of global equine joint care products is the supply of raw materials and basic ingredients (medicinal plant extracts such as curcumin and glucosamine, chemical synthetics such as hyaluronic acid and chondroitin sulfate, and carrier materials such as natural oils and gel matrices), represented by nutritional raw material giants such as DSM, BASF, and Lonza, as well as plant extract suppliers such as Naturex and Martin Bauer; the midstream is product research and development and production and manufacturing (joint creams/patches, oral nutritional supplements, and injectable biological preparations), represented by companies such as Equine HealthTech, Bayer Animal Health, and Merck Animal Health; the downstream is application scenarios and sales channels (equestrian clubs, racecourses, veterinary clinics, horse farms, and online/offline retail networks), covering competitive horses, sports horses, elderly horses, and daily health care needs.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Horses Joint Care Products market?

What factors are driving Horses Joint Care Products market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Horses Joint Care Products market opportunities vary by end market size?

How does Horses Joint Care Products break out by Type, by Application?

This report presents a comprehensive overview of the global Horses Joint Care Products market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Joint Therapeutic Products
  • Joint Supplement Products

Segment by Application

  • Horse Racing
  • Equestrian Club
  • Animal Healthcare
  • Animal Husbandry
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Horses Joint Care Products market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Horse Racing, Equestrian Club, Animal Healthcare evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Horses Joint Care Products Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$120
2025
Forecast
$162.2
2032
CAGR
4.4%
2025–2032
Regions
5
global
Key companies
Boehringer IngelheimBayer AnimalDechraCevaVetoquinolCosequinHilton HerbsAudevard
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Joint Therapeutic ProductsJoint Supplement Products
By Application
Horse RacingEquestrian ClubAnimal HealthcareAnimal HusbandryOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Joint Therapeutic Products
  • 3.1.3 Joint Supplement Products
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Horse Racing
  • 4.1.3 Equestrian Club
  • 4.1.4 Animal Healthcare
  • 4.1.5 Animal Husbandry
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Boehringer Ingelheim
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Bayer Animal
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Dechra
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ceva
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Vetoquinol
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Cosequin
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Hilton Herbs
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Audevard
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Virbac
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Noltrex
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Med - Vet Pharmaceuticals
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 SmartPak
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Nutramax Laboratories
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Equine America
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Animalife
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Platinum Performance
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Cox Vet Labs
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 4Cyte
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 ADM Protexin
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Arthramid
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Adequan
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Horses Joint Care Products market size?
The global Horses Joint Care Products market is estimated at US$ 120 million in 2025 (base year) and is projected to reach US$ 161 million by 2032.
What growth rate is expected for the Horses Joint Care Products market through 2032?
The market is expected to grow at a CAGR of 4.4% from 2026 to 2032, expanding from US$ 120 million in 2025 to US$ 161 million in 2032, roughly 1.3 times its base-year value.
How is Horses Joint Care Products defined?
In 2024, the global cost of equine joint care products will be approximately RMB 298.78/meter, with a gross profit margin of 22.73%.
How is the Horses Joint Care Products market segmented by type?
By type, the market is segmented into Joint Therapeutic Products and Joint Supplement Products.
What are the key applications of Horses Joint Care Products?
Key applications covered include Horse Racing, Equestrian Club, Animal Healthcare, Animal Husbandry and Other.
Which companies are profiled in the Horses Joint Care Products market report?
Key players profiled include Boehringer Ingelheim, Bayer Animal, Dechra, Ceva, Vetoquinol, Cosequin, Hilton Herbs and Audevard, among 21 companies covered in total.
What geographies does the Horses Joint Care Products market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Horses Joint Care Products?
What factors are driving Horses Joint Care Products market growth, globally and by region?
Who should buy the Horses Joint Care Products market report?
The report is intended for manufacturers and solution providers, distributors and end users in Horse Racing, Equestrian Club and Animal Healthcare, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Horses Joint Care Products market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.